Polymeric micelles for drug delivery

被引:439
作者
Croy, S. R.
Kwon, G. S.
机构
[1] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA
[2] GlaxoSmithKline, King Of Prussia, PA 19426 USA
关键词
block copolymers; polymeric micelles; solubilization; poloxamers; poly(ethylene glycol); physical characterization; drug delivery;
D O I
10.2174/138161206779026245
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Polymeric micelles are nanoscopic core/shell structures formed by amphiphilic block copolymers. Both the inherent and modifiable properties of polymeric micelles make them particularly well suited for drug delivery purposes. An emphasis of this review has been placed on both the description and characterization techniques of the physical properties of polymeric micelles. Relevant properties discussed include micellar association, morphology, size and stability. These properties and characterization techniques are included to provide context for the known advantages and applications of polymeric micelles for drug delivery. The advantages and applications discussed include solubilization of poorly soluble molecules, sustained release and size advantages, and protection of encapsulated substances from degradation and metabolism. The three most widely studied block copolymer classes are characterized by their hydrophobic blocks, and are poly(propylene oxide), poly(L-amino acid)s and poly(ester)s. These three classes of block copolymers are reviewed with multiple examples of current research in which formulation techniques with polymeric micelles have been applied to some of the most challenging molecules in the pharmaceutical industry. The polymeric micelles used for drug delivery in these examples have shown the abilities to attenuate toxicities, enhance delivery to desired biological sites and improve the therapeutic efficacy of active pharmaceutical ingredients.
引用
收藏
页码:4669 / 4684
页数:16
相关论文
共 156 条
[1]   Amphiphilic block copolymers for drug delivery [J].
Adams, ML ;
Lavasanifar, A ;
Kwon, GS .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (07) :1343-1355
[2]   Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles:: effects of acyl chain length [J].
Adams, ML ;
Kwon, GS .
JOURNAL OF CONTROLLED RELEASE, 2003, 87 (1-3) :23-32
[3]   Amphotericin B encapsulated in micelles based on poly(ethylene oxide)-block-poly(L-amino acid) derivatives exerts reduced in vitro hemolysis but maintains potent in vivo antifungal activity [J].
Adams, ML ;
Andes, DR ;
Kwon, GS .
BIOMACROMOLECULES, 2003, 4 (03) :750-757
[4]   The effects of acyl chain length on the micelle properties of poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugates [J].
Adams, ML ;
Kwon, GS .
JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION, 2002, 13 (09) :991-1006
[5]  
ALADE SL, 1986, PEDIATRICS, V77, P593
[6]   Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials [J].
Alakhov, V ;
Klinski, E ;
Li, SM ;
Pietrzynski, G ;
Venne, A ;
Batrakova, E ;
Bronitch, T ;
Kabanov, A .
COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) :113-134
[7]   Hypersensitization of multidrug resistant human ovarian carcinoma cells by pluronic P85 block copolymer [J].
Alakhov, VY ;
Moskaleva, EY ;
Batrakova, EV ;
Kabanov, AV .
BIOCONJUGATE CHEMISTRY, 1996, 7 (02) :209-216
[8]   Micelle aggregation numbers of surfactants in aqueous solutions: A comparison between the results from steady-state and time-resolved fluorescence quenching [J].
Alargova, RG ;
Kochijashky, II ;
Sierra, ML ;
Zana, R .
LANGMUIR, 1998, 14 (19) :5412-5418
[9]   SURFACE-ACTIVITY OF POLY(ETHYLENE OXIDE)-BLOCK-POLY(PROPYLENE OXIDE)-BLOCK-POLY(ETHYLENE OXIDE) COPOLYMERS [J].
ALEXANDRIDIS, P ;
ATHANASSIOU, V ;
FUKUDA, S ;
HATTON, TA .
LANGMUIR, 1994, 10 (08) :2604-2612
[10]   Differential scanning calorimetry investigation of the effect of salts on aqueous solution properties of an amphiphilic block copolymer (Poloxamer) [J].
Alexandridis, P ;
Holzwarth, JF .
LANGMUIR, 1997, 13 (23) :6074-6082